Patients with calcinosis |
2 |
Patients with calcinosis |
4 |
Patients with calcinosis |
6 |
Minority patients |
1 |
Minorities and disadvantaged groups |
4 |
Black patients; Asian patients; Latino patients; patients from Maghreb countries |
5 |
Young patients |
4 |
Young patients; young children; children with morphea |
1 |
Adult patients who were diagnosed as children |
5 |
Patients with gastrointestinal involvement |
1 |
Scleroderma patients with bowel problems |
3 |
Patients with gastrointestinal diseases; patients with fecal incontinence |
4 |
Patients with limited systemic sclerosis |
3 |
Patients with limited scleroderma |
1 |
Patients with mild, limited systemic sclerosis but after years of mild disease, develop pulmonary arterial hypertension |
4 |
Male patients |
1 |
Male patients with excellent health |
2 |
Men with scleroderma |
3 |
End-of-life patients |
1 |
End of life/late stage (palliative care and assisted dying) |
2 |
End of life/late stage |
3 |
Senior patients |
1 |
Senior patients |
1 |
Senior patients |
2 |
Patients with limited access to health care |
2 |
Rural patients who are far from health services; patients with limited access to health care (especially physiotherapists) |
0 |
– |
2 |
Others |
2 |
CREST (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) patients; patients with comorbid disorders (e.g. vasculitis and Sjogren’s syndrome) |
4 |
Patients with myopathy resulting in weakness and muscular atrophy; newly diagnosed patients; patients with long-standing disease (10+ years) |
6 |